The future of the weight loss market might not revolve around GLP-1 drugs.

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

Dr. Deepak Chopra warns against the brain-related risks of weight-loss drugs, emphasizing their potential to alter metabolism ...